Consensus Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:35:38 2026-08-27 am EDT			5-day change	1st Jan Change
90.50 ^CHF	-2.69%		-2.69%	-8.59%

Aug. 27	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
Aug. 27	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

be439a.RdHKyY7FpVouGTjSlTowsZ__UNiB8RsY2htxjV-GUl8.EJr4peKyxzRFTgulwUIG19eeFozCl2p5oC0eu2jJC2kQk6G4y4bSLX0rXw~b691b51fd93029f42847d3c5dbcfd716

Analysts' recommendations: Abbott Laboratories

Aug. 21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
Aug. 13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
Aug. 13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
Jul. 28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
Jul. 28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
Jul. 23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
Jul. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
Jul. 17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
Jul. 17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
Jul. 17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
Jul. 17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
Jul. 17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
Jul. 17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
Jul. 17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
Jul. 16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
Jul. 06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
Jul. 01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
Jun. 12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
May. 27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
May. 05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
Apr. 22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
Apr. 22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
Apr. 21	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
Apr. 21	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
Apr. 20	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+6.87%
	MEDTRONIC PLC					+8.34%
	CENCORA, INC.					+14.68%
	BECTON, DICKINSON AND COMPANY					+2.58%
	HOYA CORPORATION					+25.66%
	DEXCOM, INC.					+3.63%
	MEDLINE INC.					+26.46%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.93%
	TERUMO CORPORATION					+23.4%
	Average					+14.62%
	Weighted average by Cap.					+11.26%